Last updated: October 02, 2026

Application No. 17/659,274

TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORS

Final Rejection

Filed

Apr 14, 2022

Priority

May 02, 2012 — provisional 61/641,441 +5 more

Examiner

COPPINS, JANET L

Art Unit

1628

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Georgetown University

OA Round

3 (Final)

Interview Optional

— +26.1% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 73% grant rate with +26.1% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 933 resolved cases, 2023–2026

Examiner Intelligence

COPPINS, JANET L View full profile →

Grants 73% — above average

Career Allowance Rate

677 granted / 933 resolved

+12.6% vs TC avg

Strong +26% interview lift

Without

With

+26.1%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

46 currently pending

Career history

1003

Total Applications

across all art units

Statute-Specific Performance

§101

2.5%

-37.5% vs TC avg

§103

35.0%

-5.0% vs TC avg

§102

14.9%

-25.1% vs TC avg

§112

35.1%

-4.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 933 resolved cases

Prosecution Timeline

Apr 14, 2022

Application Filed

Mar 13, 2025

Non-Final Rejection mailed

Sep 09, 2025

Response Filed

Jan 07, 2026

Non-Final Rejection mailed

Apr 08, 2026

Interview Requested

Jun 05, 2026

Response Filed

Jun 08, 2026

Examiner Interview Summary

Aug 17, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/644,861

Patent 12728129

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

4y 8m to grant Granted Sep 08, 2026

17/463,099

Patent 12702150

Methods and Compositions for Slowing an Aging Process in a Human or an Animal

4y 11m to grant Granted Aug 11, 2026

18/041,211

Patent 12673955

NEW CRYSTAL FORM OF P-TOLUENESULFONATE SALT OF DIAZABICYCLIC COMPOUND AND PREPARATION METHOD THEREFOR

3y 4m to grant Granted Jul 07, 2026

17/619,752

Patent 12636297

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

4y 5m to grant Granted May 26, 2026

16/499,230

Patent 12611405

AGENT THAT INCREASES THE EXPRESSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER

6y 7m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5

Expected OA Rounds

73%

Grant Probability

99%

With Interview (+26.1%)

2y 3m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 933 resolved cases by this examiner. Grant probability derived from career allowance rate.